Albumin administration is one of the most studied interventions in patients hospitalized for
complications of decompensated cirrhosis (DC). Based on the results of randomized clinical …

Mortality in cirrhosis is mostly associated with the development of clinical decompensation,
characterized by ascites, hepatic encephalopathy, variceal bleeding, or jaundice. Therefore …

There are several indications for the use of albumin in patients with decompensated
cirrhosis and its role has existed in clinical practice for many decades. While the drug enjoys …

Albumin administration in patients with decompensated cirrhosis has been studied both in
the context of prophylaxis and management. Albumin is synthesized exclusively by the liver …

The use of human albumin is common in hepatology since international scientific societies
support its administration to treat or prevent severe complications of cirrhosis, such as the …

Albumin is the most abundant protein in the human body and is synthetized exclusively by
the liver. Therefore, serum albumin levels are reduced in acute and/or chronic liver disease …

Albumin, a negatively charged globular protein encoded on chromosome 4, is one of the
most abundant proteins in the plasma and accounts for approximately 75% of plasma …

In order to better understand the role of albumin administration in patients with
decompensated cirrhosis, certain pathophysiologic considerations of ascites and renal …

Background: Albumin is a critical component in the standard therapeutic approach to acute
renal failure (ARF) and spontaneous bacterial peritonitis (SBP) in the setting of ascites …

The burden of chronic liver disease (CLD) in the United States is growing, and it is currently
the fourth leading cause of death in adults aged 45 to 64 years. 1 From 2012 to 2016, there …